Enhanced accumulation of ribavirin and its metabolites in liver versus erythrocytes in mice administered with the liver targeted drug

Italian Journal of Gastroenterology and Hepatology

Volumn 29, Issue 5, 1997, Pages 420-426

  Di Stefano, G ^a,b,c,d   Bignamini, A ^a,b,c,d   Busi, C ^a,b,c,d   Colonna, P P ^a,b,c,d   Fiume, L ^a,b,c,d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b HyperPhar   (Italy)

^c CNR   (Italy)

^d Dipartimento di Patologia Sperimentale   (Italy)

Author keywords

Asialoglycoprotein receptor; Drug targeting; Hepatitis C; Ribavirin

Indexed keywords

POLYLYSINE; RIBAVIRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CONJUGATION; DRUG LIVER LEVEL; DRUG TARGETING; ERYTHROCYTE; FEMALE; HEMOLYSIS; HEPATITIS C; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; VIRUS TITRATION;

AMINO SUGARS; ANIMALS; ANTIVIRAL AGENTS; ERYTHROCYTES; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; MURINE HEPATITIS VIRUS; POLYLYSINE; RIBAVIRIN; TRITIUM;

EID: 0031424084     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Sidwell RW, Huffman JH, Khare GP, Alien LB, Witkowski JT, Robins RK. Broad-spectrum antiviral activity of virazole: 1-D-ribofuranosyl-l,2,4-triazole-3-carboxamide. Science 1972; 177:705-7.
2. Brillanti S, Garson J, Foli M, Whitby K, Deaville R, Masci C, et al. A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology 1994;107:812-7.
3. Chemello L, Cavalletto L, Bernardinello E, Guido M, Pontisso P, Albert! A. The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C. J Hepatol 1995;23(Suppl 2):8-12.
4. Main J. Future studies of combination therapy for chronic hepatitis C: optimizing response rates for each hepatitis C population. J Hepatol 1995:23(Suppl 2):32-6.
5. Lai MY, Kao JH, Yang PM, Wang JT, Chen PJ, Chan KW, et al. Long term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C. Gastroenterology 1996;! 11:1307-12.
6. Schalm SW, Hansen BE, Chemello L, Bellobuono A, Brouwer JT, Weiland O, et al. Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patients from European centers. J Hepatol 1997;26:961-6.
7. Catlin DH, Smith RA, Samuels AI. l4C-ribavirin: distribution and pharmacokinetic studies in rats, baboons and man. In: Smith RA, Kirkpatrick W, editors. Ribavirin a broad spectrum antiviral agent. New York: Academic Press, 1980:83-98.
8. Laskin ÖL, Longstreth JA, Hart CC, Scavuzzo D, Kaiman CM, Connor JD, et al. Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome. Clin Pharmacol Ther 1987;41:546-55.
9. Di Bisceglie AM, Bacon BR, Kleiner DE, Hoofnagle H. Increase in hepatic iron stores following prolonged therapy with ribavirin in patients with chronic hepatitis C. J Hepatol 1994;21:1109-12.
10. Fiel MI, Guido M, Thung SN, Lindsay KL, Davis GL, Lewis JH, et al. Hepatic iron deposition during ribavirin therapy of chronic hepatitis C. Hepatology 1995;22:290A.
11. Olynyk KJ, Reddy R, Di Bisceglie AM, Jeffers LJ, Parker TI, Radick JI, et al. Hepatic iron concentration as a predictor factor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995;108:1104-9.
12. Murakami CS, Wheeler D, Foster S, Mclntire D, Cheng QC, Casey DL, et al. Histology and hepatic iron content predict response to interferon in chronic hepatitis C. Hepatology 1995;22:291A.
13. Canonico PJ, Kastello MD, Spears CT, Brown JR, Jackson EA, Jenkins DE. Effects of ribavirin on red blood cells. Tox Appl Pharm 1984 ;74:155-62.
14. Di Stefano G, Colonna FP, Bongini A, Busi C, Mattioli A, Fiume L. Ribavirin conjugated with lactosaminated poly-L-lysine: selective delivery to the liver and increased antiviral activity in mice with viral hepatitis. Biochem Pharmacol 1997;54:357-63.
15. Fiume L, Di Stefano G, Busi C, Mattioli A. A conjugate of lactosaminated poly-L-lysine with adenine arabinoside monophosphate, administered to mice by intramuscular route, accomplishes a selective delivery of the drug to the liver. Biochem Pharmacol 1994;47:643-50.
16. Di Stefano G, Busi C, Mattioli A, Fiume L. Selective delivery to the liver of antiviral nucleoside analogs coupled to a high molecular mass lactosaminated poly-L-lysine and administered to mice by intramuscular route. Biochem Pharmacol 1995;49:1769-75.
17. Fiume L, Di Stefano G, Busi C, Mattioli A, Rapicetta M, Giuseppetti R, et al. Inhibition of woodchuck hepatitis virus replication by adenine arabinoside monophosphate coupled to lactosaminated poly-L-lysine and administered by intramuscular route. Hepatology 1995:22:1072-7.
18. Fiume L, Di Stefano G, Busi C, Mattioli A, Gervasi GB, Bertini M, et al. The hepatotropic conjugate of adenine arabinoside monophosphate with lactosaminated poly-L-lysine. Synthesis of the carrier and pharmacological properties of the conjugate. J Hepatol 1997:26:253-9.
19. Damha MS, Ogilvir KK. Oligoribonucleotides synthesis: the sylil-phosphoramidite method. In Agrawal S, editor. Protocols for oligonucleotides and analogs. Synthesis and properties. Methods in molecular biology. Vol. 20. Totowa, NJ: Humane Press, 1993:81-114.
20. Parick JR, Doring WE. Sulfur trioxide in the oxidation of alcohols by dimethyl sulphoxide. J Am Chem Soc 1967;89:5505-7.
21. Crel GM, Mackie DW, Perlin AS. Facile elimination accompanying some methyl sulphoxide oxidation. Formation of unsaturated carbohydrates. Can J Chem 1969;47:511-2.
22. Vogel AJ. Practical organic chemistry. 3td edition. London; Longman, 1966.
23. Wauzlich HW, Löchel W. 1-2 Dianilino-athan als Aldehydreagens. Chem Ber 1953;! 1:1463-6.
24. Colonna S, Fornasier R. N-dodeyl-N-methylephedrinium bromide: a specific catalyst for the borohydride reduction of car-bonyl compounds under phase transfer conditions. Synthesis 1975:531-2.
25. Fiume L, Busi C, Di Stefano G, Mattioli A. Coupling of antiviral nucleoside analogs to lactosaminated human albumin by using the imidazolides of their phosphoric esters. Anal Biochem 1993;212:407-11.
26. Schwartz BA, Gray GR. Proteins containing reductively aminated disaccharides: synthesis and chemical characterization. Arch Biochem Biophys 1977;181:542-9.
27. Patterson JL, Femandez-Larsson R. Molecular mechanisms of action of ribavirin. Rev Infec Dis 1990;12:1139-46.
28. Mishra NC, Broom AD. A novel synthesis of nucleoside 5'triphosphates. J Chem Soc Chem Comm 1991:1276-7.
29. Sidwell RW, Huffman JH, Campbell N, Allen LB. Effect of ribavirin on viral hepatitis in laboratory animals. Ann NY Acad Sei 1977;284:239-46.
30. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Hyg 1938;27:493-7.
31. Page T, Connor JD. The metabolism of ribavirin in erythrocytes and nucleated cells. Int J Biochem 1990;22:379-83.
32. Miller JP, Kigwana LJ, Streeter DJ, Robins RK, Simon LN, Roboz J. The relationship between the metabolism of ribavirin and its proposed mechanism of action. Ann NY Acad Sei 1977;284:211-29.
33. Weiss RC, Oostrom-Ram T. Inhibitory effects of ribavirin alone or combined with human alpha interferon on feline infectious peritonitis virus replication in vitro. Veter Microbiol 1989:20:255-65.
34. Okada I, Matsumori A, Matoba Y, Tominaga M, Yamada T, Kawai C. Combination treatment with ribavirin and interferon for Coxsackievirus B3 replication. J Lab Clin Med 1992; 120:569-723.
35. Gross M, Reiter S, Zollner N. Metabolism of D-ribose administered continuously to healthy persons and to patients with myoadenylate deaminase deficiency. Klin Wochenschr 1989:67:120513.
36. Blight KJ, Gowans EJ. In situ hybridization and immunohistochemical staining of hepatitis C virus products. Viral Hepatitis Rev 1995:1:143-55.
37. Blight K, Rowland R, Hall PM, Lesniewski RR, Trowbridge R, LaBrooy JT, et al. Immunohistochemical detection of the NS4 antigen of hepatitis C virus and its relation to histopathology. Am JPathol 1993:143:1568-73.
38. Gil B, Qian C, Riezu-Boj JI, Civeira MP, Prieto J. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment. Hepatology 1993:18:1050-4.
39. Bonkovsky HL, Banner BF, Rothman AL. Iron and chronic viral hepatitis. Hepatology 1997;25:759-68.